Landscapes / Targets
neoantigens
12 drugs act on neoantigens, in 24 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs12
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Personalised mRNA cancer vaccine |
Merck & Co. +1 · Public MRK · MRNA |
Phase 3 | 23 Apr 2027Phase 1/2 trial completes | ||
| Next date | 23 Apr 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Melanoma, Non-small Cell Lung Cancer and 9 more | ||||
| Open drug page | |||||
— |
Phase 2/3 | Nov 2030Phase 2/3 trial completes | |||
| Next date | Nov 2030 · Phase 2/3 trial completes | ||||
| Also tested for | Glioblastoma Multiforme of Brain | ||||
| Open drug page | |||||
— |
Phase 1/2 | Aug 2027Phase 1/2 trial completes | |||
| Next date | Aug 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Solid Tumors, Advanced Cancer and 3 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 30 Dec 2027Phase 1/2 trial completes | |||
| Next date | 30 Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Squamous Cell Carcinoma of Head and Neck | ||||
| Open drug page | |||||
— |
Phase 1/2 | 31 Dec 2027Phase 1/2 trial completes | |||
| Next date | 31 Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Solid Tumors, Adult, Solid Tumor and 1 more | ||||
| Open drug page | |||||
Ciclopirox Olaminenot checked |
— |
Phase 1/2 | 1 May 2028Phase 1/2 trial completes | ||
| Next date | 1 May 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Congenital Erythropoietic Porphyria (CEP) | ||||
| Open drug page | |||||
— |
Phase 2 | Sep 2029Phase 2 trial completes | |||
| Next date | Sep 2029 · Phase 2 trial completes | ||||
| Also tested for | HCC | ||||
| Open drug page | |||||
— |
Phase 1/2 | Dec 2030Phase 1/2 trial completes | |||
| Next date | Dec 2030 · Phase 1/2 trial completes | ||||
| Also tested for | Colorectal Cancer | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | Solid Tumor, Adult | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | Solid Tumor, Adult | ||||
| Open drug page | |||||
— |
Akeso · Public 9926.HK |
Phase 1 | 23 Feb 2028Phase 1 trial completes | ||
| Next date | 23 Feb 2028 · Phase 1 trial completes | ||||
| Also tested for | Pancreas Cancer, Pancreas Cancer, Duct Cell Adenocarcinoma | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Oct 2029Phase 1 trial completes | |||
| Next date | 30 Oct 2029 · Phase 1 trial completes | ||||
| Also tested for | Biliary Cancer (Cholangiocarcinoma, Gall Bladder Cancer), Pancreatic Ductal Adenocarcinoma (PDAC) and 2 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 11 of 12 drugs. The other 1 is marked “not checked” in the list. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026